Tambocor

(redirected from flecainide acetate)
Also found in: Thesaurus, Medical.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.Tambocor - oral antiarrhythmic medication (trade name Tambocor) used as a last resort in treating arrhythmias; increases the risk of sudden death in heart attack patients
flecainide
antiarrhythmic, antiarrhythmic drug, antiarrhythmic medication - a drug used to treat an abnormal heart rhythm
brand, brand name, marque, trade name - a name given to a product or service
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Mentioned in ?
References in periodicals archive ?
Pharmacokinetics of flecainide acetate in patients with severe renal impairment.
Flecainide toxicity in renal failure
M2 EQUITYBITES-December 30, 2015-ANI Pharmaceuticals introduces Flecainide Acetate tablets
ANI Pharmaceuticals introduces Flecainide Acetate tablets
M2 PHARMA-December 30, 2015-ANI Pharmaceuticals introduces Flecainide Acetate tablets
ANI Pharmaceuticals introduces Flecainide Acetate tablets
has received final approval from the FDA for the generic equivalent to the reference listed drug (RLD), Tambocor Tablets, 50 mg, 100 mg, and 150 mg (flecainide acetate tablets, USP).
Product pipeline continues to give patients more options
The patient's history was notable for hypertension treated with amlodipine and atrial fibrillation treated with pharmacologic cardioversion many years before, in prophylactic treatment with flecainide acetate. However, the patient was suffering from recurrent paroxysmal episodes of supraventricular tachycardia.
Incidental retroperitoneal paraganglioma in patient candidate to radical prostatectomy: concurrent surgical treatments by robotic approach
(Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that it will launch Tambocor Fine Granules 10%, a new formulation of anti-arrhythmic agent Tambocor (flecainide acetate), on June 29 in Japan.
Eisai to Launch New Fine Granule Formulation of Tachyarrhythmia Treatment Tambocor Suitable for Pediatric Patients in Japan
(NASDAQ: ANIP) has acquired the approved abbreviated new drug application for Flecainide Acetate tablets USP 50mg, 100mg and 150mg, previously marketed by Teva Pharmaceuticals, the company said on Thursday.
ANI Pharmaceuticals Acquires Generic Heart Drug Teva
Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias.
Efficacy of Agents for Pharmacologic Conversion of Atrial Fibrillation and Subsequent Maintenance of Sinus Rhythm

Dictionary browser ?
Full browser ?